Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matsui

Showing results (631-640 of 735) with videos related to

Pageof 74
Sort By:
British Journal of Cancer|October 1, 1993
Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1993
Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenograftsS Kudoh, M Takada, N Masuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity]K Kitajima, M Fukuoka, S Kobayashi, et al.
Carbohydrate Research|February 5, 1998
Enzymatic synthesis of the glycosides of calystegines B1 and B2 and their glycosidase inhibitory activitiesN Asano, A Kato, H Kizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancerN Masuda, M Fukuoka, M Takada, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1995
Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatinS Kudoh, M Fukuoka, N Masuda, et al.
Journal of the National Cancer Institute|December 4, 1991
Establishment of tumor cell lines as an independent prognostic factor for survival time in patients with small-cell lung cancerN Masuda, M Fukuoka, K Matsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]N Takifuji, M Fukuoka, S Negoro, et al.
Radiology|July 29, 1998
Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapyT Tada, K Minakuchi, M Koda, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2021
Ras-like Gem GTPase induced by Npas4 promotes activity-dependent neuronal tolerance for ischemic strokeHiroo Takahashi, Ryo Asahina, Masayuki Fujioka, et al.
Pageof 74

Showing results (631-640 of 735) with videos related to

Sort By:
Pageof 74
British Journal of Cancer|October 1, 1993
Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1993
Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenograftsS Kudoh, M Takada, N Masuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1987
[Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity]K Kitajima, M Fukuoka, S Kobayashi, et al.
Carbohydrate Research|February 5, 1998
Enzymatic synthesis of the glycosides of calystegines B1 and B2 and their glycosidase inhibitory activitiesN Asano, A Kato, H Kizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancerN Masuda, M Fukuoka, M Takada, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1995
Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatinS Kudoh, M Fukuoka, N Masuda, et al.
Journal of the National Cancer Institute|December 4, 1991
Establishment of tumor cell lines as an independent prognostic factor for survival time in patients with small-cell lung cancerN Masuda, M Fukuoka, K Matsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]N Takifuji, M Fukuoka, S Negoro, et al.
Radiology|July 29, 1998
Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapyT Tada, K Minakuchi, M Koda, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2021
Ras-like Gem GTPase induced by Npas4 promotes activity-dependent neuronal tolerance for ischemic strokeHiroo Takahashi, Ryo Asahina, Masayuki Fujioka, et al.
Pageof 74